Chronic Migraine
Chronic migraine is a neurological condition characterized by recurrent headaches that occur 15 or more days a month, often accompanied by symptoms like nausea, sensitivity to light, and visual disturbances.
Chronic Migraine in Adolescents: Rimegepant Study
We are investigating whether rimegepant can help prevent migraines in adolescents aged 12 to under 18 with chronic migraine. The study will also assess its safety and how it affects the use of other migraine treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 12 and 17 years old?
- Do you have a history of having at least 15 headache days per month for the last 3 months?
- Are you currently taking any medications for migraine prevention, like Nurtec™ or others?
- Have you had a continuous migraine (unrelenting headache) in the last month?
- Do you have any current psychiatric condition that is uncontrolled or untreated?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Fakultni Nemocnice Brno
Klinika dětské neurologie
Brno, Czechia
Fakultni Nemocnice Ostrava
Oddělení dětské neurologie
Hlučín, Czechia
Fakultni Nemocnice Hradec Kralove
Neurologická klinika
Hradec Králové, Czechia
Sponsor: Pfizer Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.